Jin-long Chen, Chief Scientific Officer at NGM BIOPHARMACEUTICALS INC (NGM), sold 83,607 shares at $17.95 ($1.5M) on 2020-01-09, disclosed to the SEC on 2020-01-09.
Open-market sale of $1.5M NGM by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.20 | 16,090 | $293K | 19.4% |
| 2 | $17.98 | 1,833 | $33K | 2.2% |
| 3 | $17.98 | 14,201 | $255K | 17.0% |
| 4 | $17.98 | 14,201 | $255K | 17.0% |
| 5 | $17.95 | 18,641 | $335K | 22.2% |
| 6 | $17.95 | 18,641 |
| $335K |
| 22.2% |
| Total | $18.01 avg | 83,607 | $1.5M | 100% |
| Filing → |
| NGM | SELL | 2021-11-16 | $592K | — | Filing → |
| NGM | SELL | 2021-10-13 | $608K | — | Filing → |
| NGM | SELL | 2021-09-14 | $1.5M | — | Filing → |